Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy

ClinicalTrials.gov ID: NCT00233402

Public ClinicalTrials.gov record NCT00233402. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to document the additional detection of papillary bladder cancer and the reduced early recurrence due to the improved detection and resection of these tumors after Hexvix cystoscopy compared to standard cystoscopy in patients with papillary bladder cancer.

Study identification

NCT ID
NCT00233402
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Photocure
Industry
Enrollment
789 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Oct 11, 2013

2005 – 2008

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Stanford Cancer Center, Department of Urology Stanford California 94305-5820 —
V.A. Medical Center Gainesville Florida 32608 —
University of Miami School of Medicine Miami Florida 33136 —
South Florida Clinical Research Center, Inc. Pembroke Pines Florida 33028 —
The Emory Clinic, Dept of Urology Atlanta Georgia 30322 —
Boston University School of Medicine Boston Massachusetts 02118 —
St. Joseph Mercy Hospital- Ann Arbor Ann Arbor Michigan 48106 —
Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester Rochester Minnesota 55905 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Mount Sinai Medical Center, Department of Urology New York New York 10029-6574 —
URMC Rochester New York 14642 —
Urological Institute at Beachwood Cleveland Clinic Beachwood Ohio 44120 —
Thomas Jefferson Medical College, Department of Neurology Philadelphia Pennsylvania 19107 —
Vanderbilt University Medical Center, Department of Urologic Surgery Nashville Tennessee 37232-2765 —
Baylor College of Medicine, Scott Department of Urology Houston Texas 77030-2726 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00233402, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2013 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00233402 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →